Control of vascular smooth muscle function by Src-family kinases and reactive oxygen species in health and disease

Journal of Physiology

Volumn 593, Issue 17, 2015, Pages 3815-3828

  Mackay, Charles E ^a   Knock, Greg A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; DASATINIB; FOCAL ADHESION KINASE; FOCAL ADHESION KINASE 1; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR; IMATINIB; JANUS KINASE; MYOSIN PHOSPHATASE; PHOSPHATASE; POTASSIUM CHANNEL; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; STAT3 PROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ACTIN FILAMENT; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; DRUG POTENCY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HYPOXIA; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PULMONARY ARTERY; PULMONARY HYPERTENSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; VASCULAR SMOOTH MUSCLE; ANIMAL; METABOLISM; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; HUMANS; HYPERTENSION, PULMONARY; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; REACTIVE OXYGEN SPECIES; SRC-FAMILY KINASES;

EID: 84940526939     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2014.285304     Document Type: Article

References (98)

1. Abdalla S & Will JA (1995). Potentiation of the hypoxic contraction of guinea-pig isolated pulmonary arteries by two inhibitors of superoxide dismutase. Gen Pharmacol 26, 785-792.
2. Akhand AA, Pu M, Senga T, Kato M, Suzuki H, Miyata T, Hamaguchi M & Nakashima I (1999). Nitric oxide controls Src kinase activity through a sulfhydryl group modification-mediated Tyr-527-independent and Tyr-416-linked mechanism. J Biol Chem 274, 25821-25826.
3. + channels as a new mechanism of agonist-induced vasoconstriction. Proc Natl Acad Sci USA 99, 14560-14565.
4. Andreev J, Galisteo ML, Kranenburg O, Logan SK, Chiu ES, Okigaki M, Cary LA, Moolenaar WH & Schlessinger J (2001). Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade. J Biol Chem 276, 20130-20135.
5. Banes-Berceli AK, Ogobi S, Tawfik A, Patel B, Shirley A, Pollock DM, Fulton D & Marrero MB (2005). Endothelin-1 activation of JAK2 in vascular smooth muscle cells involves NAD(P)H oxidase-derived reactive oxygen species. Vascul Pharmacol 43, 310-319.
6. 2-arachidonic acid signaling cascade in coronary artery smooth muscle. Am J Physiol Heart Circ Physiol 279, H475-H483.
7. Bedard K & Krause KH (2007). The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87, 245-313.
8. Berghausen E, ten Freyhaus H & Rosenkranz S (2013). Targeting of platelet-derived growth factor signaling in pulmonary arterial hypertension. Handb Exp Pharmacol 218, 381-408.
9. Bos JL, Rehmann H & Wittinghofer A (2007). GEFs and GAPs: critical elements in the control of small G proteins. Cell 129, 865-877.
10. Calalb MB, Polte TR & Hanks SK (1995). Tyrosine phosph-orylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol 15, 954-963.
11. Cario-Toumaniantz C, Ferland-McCollough D, Chadeuf G, Toumaniantz G, Rodriguez M, Galizzi JP, Lockhart B, Bril A, Scalbert E, Loirand G & Pacaud P (2012). RhoA guanine exchange factor expression profile in arteries: evidence for a Rho kinase-dependent negative feedback in angiotensin II-dependent hypertension. Am J Physiol Cell Physiol 302, C1394-C1404.
12. 2 under U46619 stimulation in pulmonary artery smooth muscle cells. Arch Biochem Biophys 523, 169-180.
13. Chan DA, Sutphin PD, Denko NC & Giaccia AJ (2002). Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1α. J Biol Chem 277, 40112-40117.
14. Chandra S, Romero MJ, Shatanawi A, Alkilany AM, Caldwell RB & Caldwell RW (2012). Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway. Br J Pharmacol 165, 506-519.
15. Chen CH, Cheng TH, Lin H, Shih NL, Chen YL, Chen YS, Cheng CF, Lian WS, Meng TC, Chiu WT & Chen JJ (2006). Reactive oxygen species generation is involved in epidermal growth factor receptor transactivation through the transient oxidization of Src homology 2-containing tyrosine phosphatase in endothelin-1 signaling pathway in rat cardiac fibroblasts. Mol Pharmacol 69, 1347-1355.
16. Chiarugi P, Pani G, Giannoni E, Taddei L, Colavitti R, Raugei G, Symons M, Borrello S, Galeotti T & Ramponi G (2003). Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J Cell Biol 161, 933-944.
17. Chou MT, Anthony J, Bjorge JD & Fujita DJ (2010). The von Hippel-Lindau tumor suppressor protein is destabilized by Src: Implications for tumor angiogenesis and progression. Genes Cancer 1, 225-238.
18. Choudhury GG, Mahimainathan L, Das F, Venkatesan B & Ghosh-Choudhury N (2006). c-Src couples PI 3 kinase/Akt and MAPK signaling to PDGF-induced DNA synthesis in mesangial cells. Cell Signal 18, 1854-1864.
19. phox in hyperoxia-induced activation of NADPH oxidase and generation of reactive oxygen species in lung endothelial cells. J Biol Chem 280, 20700-20711.
20. 2+ release. J Physiol 591, 4473-4498.
21. Courboulin A, Paulin R, Giguere NJ, Saksouk N, Perreault T, Meloche J, Paquet ER, Biardel S, Provencher S, Cote J, Simard MJ & Bonnet S (2011). Role for miR-204 in human pulmonary arterial hypertension. J Exp Med 208, 535-548.
22. Crosswhite P & Sun Z (2010). Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension. J Hypertens 28, 201-212.
23. Cuevas BD, Lu Y, Mao M, Zhang J, LaPushin R, Siminovitch K & Mills GB (2001). Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase. J Biol Chem 276, 27455-27461.
24. Daou GB & Srivastava AK (2004). Reactive oxygen species mediate endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 signaling, as well as protein synthesis, in vascular smooth muscle cells. Free Radic Biol Med 37, 208-215.
25. 2+ regulation. Cardiovasc Res 67, 308-316.
26. 411 in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt. J Biol Chem 274, 36843-36851.
27. 3 adenosine receptor in mice. J Pharmacol Exp Ther 338, 711-717.
28. Frame MC, Fincham VJ, Carragher NO & Wyke JA (2002). v-Src's hold over actin and cell adhesions. Nat Rev Mol Cell Biol 3, 233-245.
29. Frank GD, Eguchi S, Inagami T & Motley ED (2001). N-Acetylcysteine inhibits angiotensin II-mediated activation of extracellular signal-regulated kinase and epidermal growth factor receptor. Biochem Biophys Res Commun 280, 1116-1119.
30. Frank GD, Mifune M, Inagami T, Ohba M, Sasaki T, Higashiyama S, Dempsey PJ & Eguchi S (2003). Distinct mechanisms of receptor and nonreceptor tyrosine kinase activation by reactive oxygen species in vascular smooth muscle cells: role of metalloprotease and protein kinase C-δ. Mol Cell Biol 23, 1581-1589.
31. 2+ and PKCδfor Janus kinase 2 activation by angiotensin II: involvement of PYK2. Mol Endocrinol 16, 367-377.
32. Funato Y & Miki H (2014). Reversible oxidation of PRL family protein-tyrosine phosphatases. Methods 65, 184-189.
33. Gadepalli R, Singh NK, Kundumani-Sridharan V, Heckle MR & Rao GN (2012). Novel role of proline-rich nonreceptor tyrosine kinase 2 in vascular wall remodeling after balloon injury. Arterioscler Thromb Vasc Biol 32, 2652-2661.
34. Geneste O, Copeland JW & Treisman R (2002). LIM kinase and Diaphanous cooperate to regulate serum response factor and actin dynamics. J Cell Biol 157, 831-838.
35. Giannoni E, Buricchi F, Raugei G, Ramponi G & Chiarugi P (2005). Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol Cell Biol 25, 6391-6403.
36. Godinas L, Guignabert C, Seferian A, Perros F, Bergot E, Sibille Y, Humbert M & Montani D (2013). Tyrosine kinase inhibitors in pulmonary arterial hypertension: a double-edge sword? Semin Respir Crit Care Med 34, 714-724.
37. Gonzales AL, Yang Y, Sullivan MN, Sanders L, Dabertrand F, Hill-Eubanks DC, Nelson MT & Earley S (2014). A PLCγ1-dependent, force-sensitive signaling network in the myogenic constriction of cerebral arteries. Sci Signal 7, ra49.
38. + channels by integrin signaling. Adv Exp Med Biol 674, 69-79.
39. Guilluy C, Bregeon J, Toumaniantz G, Rolli-Derkinderen M, Retailleau K, Loufrani L, Henrion D, Scalbert E, Bril A, Torres RM, Offermanns S, Pacaud P & Loirand G (2010). The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure. Nat Med 16, 183-190.
40. i proteins and hyperproliferation of vascular smooth muscle cells from SHR: role of ROS and ROS-mediated signaling. Am J Physiol Cell Physiol 304, C1198-C1209.
41. Heeneman S, Haendeler J, Saito Y, Ishida M & Berk BC (2000). Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor βreceptor. Key role for the p66 adaptor protein Shc. J Biol Chem 275, 15926-15932.
42. Ichikawa K, Ito M & Hartshorne DJ (1996). Phosphorylation of the large subunit of myosin phosphatase and inhibition of phosphatase activity. J Biol Chem 271, 4733-4740.
43. Iqbal N & Iqbal N (2014). Imatinib: a breakthrough of targeted therapy in cancer. Chemother Res Pract 2014, 357027.
44. Janssen-Heininger YM, Mossman BT, Heintz NH, Forman HJ, Kalyanaraman B, Finkel T, Stamler JS, Rhee SG & van der Vliet A (2008). Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic Biol Med 45, 1-17.
45. 2-induced contraction in pulmonary artery. Am J Physiol Heart Circ Physiol 272, H2686-H2692.
46. Karoor V, Oka M, Walchak SJ, Hersh LB, Miller YE & Dempsey EC (2013). Neprilysin regulates pulmonary artery smooth muscle cell phenotype through a platelet-derived growth factor receptor-dependent mechanism. Hypertension 61, 921-930.
47. 2+ entry channels. Proc Natl Acad Sci USA 103, 335-340.
48. 2+-sensiti-zation of rat pulmonary artery. Cardiovasc Res 77, 570-579.
49. 2+ sensitization. Free Radic Biol Med 46, 633-642.
50. Knock GA, Snetkov VA, Shaifta Y, Drndarski S, Ward JP & Aaronson PI (2008b). Role of src-family kinases in hypoxic vasoconstriction of rat pulmonary artery. Cardiovasc Res 80, 453-462.
51. Knock GA & Ward JP (2011). Redox regulation of protein kinases as a modulator of vascular function. Antioxid Redox Signal 15, 1531-1547.
52. Krymskaya VP, Goncharova EA, Ammit AJ, Lim PN, Goncharov DA, Eszterhas A & Panettieri RA Jr (2005). Src is necessary and sufficient for human airway smooth muscle cell proliferation and migration. FASEB J 19, 428-430.
53. Lim Y Jr, Lim ST, Tomar A, Gardel M, Bernard-Trifilo JA, Chen XL, Uryu SA, Canete-Soler R, Zhai J, Lin H, Schlaepfer WW, Nalbant P, Bokoch G, Ilic D, Waterman-Storer C & Schlaepfer DD (2008). PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility. J Cell Biol 180, 187-203.
54. phox). Am J Physiol Lung Cell Mol Physiol 290, L2-L10.
55. Lu Y, Yu Q, Liu JH, Zhang J, Wang H, Koul D, McMurray JS, Fang X, Yung WK, Siminovitch KA & Mills GB (2003). Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades. J Biol Chem 278, 40057-40066.
56. Madamanchi NR, Moon SK, Hakim ZS, Clark S, Mehrizi A, Patterson C & Runge MS (2005). Differential activation of mitogenic signaling pathways in aortic smooth muscle cells deficient in superoxide dismutase isoforms. Arterioscler Thromb Vasc Biol 25, 950-956.
57. Mills JE, Whitford PC, Shaffer J, Onuchic JN, Adams JA & Jennings PA (2007). A novel disulfide bond in the SH2 domain of the C-terminal Src kinase controls catalytic activity. J Mol Biol 365, 1460-1468.
58. Min J, Reznichenko M, Poythress RH, Gallant CM, Vetterkind S, Li Y & Morgan KG (2012). Src modulates contractile vascular smooth muscle function via regulation of focal adhesions. J Cell Physiol 227, 3585-3592.
59. Nagaraj C, Tang B, Balint Z, Wygrecka M, Hrzenjak A, Kwapiszewska G, Stacher E, Lindenmann J, Weir EK, Olschewski H & Olschewski A (2013). Src tyrosine kinase is crucial for potassium channel function in human pulmonary arteries. Eur Respir J 41, 85-95.
60. 2+ sensitization of coronary artery contraction mediated by a sphingosylphosphorylcholine-Rho-kinase pathway. Circ Res 91, 953-960.
61. Nakashima H, Suzuki H, Ohtsu H, Chao JY, Utsunomiya H, Frank GD & Eguchi S (2006). Angiotensin II regulates vascular and endothelial dysfunction: recent topics of angiotensin II type-1 receptor signaling in the vasculature. Curr Vasc Pharmacol 4, 67-78.
62. Nobes CD & Hall A (1995). Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81, 53-62.
63. Oeckler RA, Kaminski PM & Wolin MS (2003). Stretch enhances contraction of bovine coronary arteries via an NAD(P)H oxidase-mediated activation of the extracellular signal-regulated kinase mitogen-activated protein kinase cascade. Circ Res 92, 23-31.
64. Paulin R, Meloche J, Jacob MH, Bisserier M, Courboulin A & Bonnet S (2011). Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol 301, H1798-H1809.
65. Pullamsetti SS, Berghausen EM, Dabral S, Tretyn A, Butrous E, Savai R, Butrous G, Dahal BK, Brandes RP, Ghofrani HA, Weissmann N, Grimminger F, Seeger W, Rosenkranz S & Schermuly RT (2012). Role of Src tyrosine kinases in experimental pulmonary hypertension. Arterioscler Thromb Vasc Biol 32, 1354-1365.
66. Ravichandran KS (2001). Signaling via Shc family adapter proteins. Oncogene 20, 6322-6330.
67. Reis GS, Augusto VS, Silveira AP, Jordao AA Jr, Baddini-Martinez J, Poli NO, Rodrigues AJ & Evora PR (2013). Oxidative-stress biomarkers in patients with pulmonary hypertension. Pulm Circ 3, 856-861.
68. Ridley AJ & Hall A (1992). The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70, 389-399.
69. Roskoski R Jr (2005). Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun 331, 1-14.
70. Saito S, Frank GD, Mifune M, Ohba M, Utsunomiya H, Motley ED, Inagami T & Eguchi S (2002). Ligand-independent trans-activation of the platelet-derived growth factor receptor by reactive oxygen species requires protein kinase C-δand c-Src. J Biol Chem 277, 44695-44700.
71. Saito Y & Berk BC (2001). Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors. J Mol Cell Cardiol 33, 3-7.
72. Sato H, Sato M, Kanai H, Uchiyama T, Iso T, Ohyama Y, Sakamoto H, Tamura J, Nagai R & Kurabayashi M (2005). Mitochondrial reactive oxygen species and c-Src play a critical role in hypoxic response in vascular smooth muscle cells. Cardiovasc Res 67, 714-722.
73. Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, Sydykov A, Lai YJ, Weissmann N, Seeger W & Grimminger F (2005). Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115, 2811-2821.
74. Seferian A, Chaumais MC, Savale L, Günther S, Tubert-Bitter P, Humbert M & Montani D (2013). Drugs induced pulmonary arterial hypertension. Presse Med 42, e303-e310.
75. FAK) in cultured rat cardiac myocytes. Biochem Biophys Res Commun 262, 290-296.
76. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y & Griendling KK (2002). Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 91, 406-413.
77. Shah AM, Campbell P, Rocha GQ, Peacock A, Barst RJ, Quinn D & Solomon SD (2014). Effect of imatinib as add-on therapy on echocardiographic measures of right ventricular function in patients with significant pulmonary arterial hypertension. Eur Heart J (in press; DOI: http://dx.doi.org/10.1093/eurheartj/ehu035).
78. Shimoda LA & Laurie SS (2014). HIF and pulmonary vascular responses to hypoxia. J Appl Physiol (1985) 116, 867-874.
79. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N & Souza R (2009). Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54, S43-S54.
80. Singh NK, Wang D, Kundumani-Sridharan V, Van QD, Niu J & Rao GN (2011). 15-Lipoxygenase-1-enhanced Src-Janus kinase 2-signal transducer and activator of transcription 3 stimulation and monocyte chemoattractant protein-1 expression require redox-sensitive activation of epidermal growth factor receptor in vascular wall remodeling. J Biol Chem 286, 22478-22488.
81. Smith KA & Yuan JX (2014). Hypoxia-inducible factor-1αin pulmonary arterial smooth muscle cells and hypoxia-induced pulmonary hypertension. Am J Respir Crit Care Med 189, 245-246.
82. Snetkov VA, Smirnov SV, Kua J, Aaronson PI, Ward JP & Knock GA (2011). Superoxide differentially controls pulmonary and systemic vascular tone through multiple signalling pathways. Cardiovasc Res 89, 214-224.
83. Sreenivasappa H, Chaki SP, Lim SM, Trzeciakowski JP, Davidson MW, Rivera GM & Trache A (2014). Selective regulation of cytoskeletal tension and cell-matrix adhesion by RhoA and Src. Integr Biol (Camb) 6, 743-754.
84. 2A receptor and Src tyrosine kinase. Exp Mol Med 45, e67.
85. ten Freyhaus H, Dagnell M, Leuchs M, Vantler M, Berghausen EM, Caglayan E, Weissmann N, Dahal BK, Schermuly RT, Ostman A, Kappert K & Rosenkranz S (2011). Hypoxia enhances platelet-derived growth factor signaling in the pulmonary vasculature by down-regulation of protein tyrosine phosphatases. Am J Respir Crit Care Med 183, 1092-1102.
86. Timpson P, Jones GE, Frame MC & Brunton VG (2001). Coordination of cell polarization and migration by the Rho family GTPases requires Src tyrosine kinase activity. Curr Biol 11, 1836-1846.
87. Turrens JF (2003). Mitochondrial formation of reactive oxygen species. J Physiol 552, 335-344.
88. Uzui H, Lee JD, Shimizu H, Tsutani H & Ueda T (2000). The role of protein-tyrosine phosphorylation and gelatinase production in the migration and proliferation of smooth muscle cells. Atherosclerosis 149, 51-59.
89. Vazquez G, Wedel BJ, Kawasaki BT, Bird GS & Putney JW Jr (2004). Obligatory role of Src kinase in the signaling mechanism for TRPC3 cation channels. J Biol Chem 279, 40521-40528.
90. Velasco G, Armstrong C, Morrice N, Frame S & Cohen P (2002). Phosphorylation of the regulatory subunit of smooth muscle protein phosphatase 1 M at Thr850 induces its dissociation from myosin. FEBS Lett 527, 101-104.
91. Vepa S, Scribner WM, Parinandi NL, English D, Garcia JG & Natarajan V (1999). Hydrogen peroxide stimulates tyrosine phosphorylation of focal adhesion kinase in vascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 277, L150-L158.
92. Wang Y, Ji L, Jiang R, Zheng L & Liu D (2014). Oxidized high-density lipoprotein induces the proliferation and migration of vascular smooth muscle cells by promoting the production of ROS. J Atheroscler Thromb 21, 204-216.
93. Ward CW, Gough KH, Rashke M, Wan SS, Tribbick G & Wang J (1996). Systematic mapping of potential binding sites for Shc and Grb2 SH2 domains on insulin receptor substrate-1 and the receptors for insulin, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor. J Biol Chem 271, 5603-5609.
94. Waypa GB, Marks JD, Guzy RD, Mungai PT, Schriewer JM, Dokic D, Ball MK & Schumacker PT (2013). Superoxide generated at mitochondrial complex III triggers acute responses to hypoxia in the pulmonary circulation. Am J Respir Crit Care Med 187, 424-432.
95. Wedgwood S, Dettman RW & Black SM (2001). ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 281, L1058-L1067.
96. Wong WK, Knowles JA & Morse JH (2005). Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension. Am J Respir Cell Mol Biol 33, 438-446.
97. Wu W, Platoshyn O, Firth AL & Yuan JX (2007). Hypoxia divergently regulates production of reactive oxygen species in human pulmonary and coronary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 293, L952-L959.
98. Xu W, Doshi A, Lei M, Eck MJ & Harrison SC (1999). Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol Cell 3, 629-638.